Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis

Background: The distribution of adverse events (AEs) triggered by immune checkpoint inhibitors (ICIs) across different cancer types has never been demonstrated. Methods: Randomised controlled trials exclusively assessing ICI monotherapy in cohorts of over 100 patients were considered. Our primary ou...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuhui Tong, Rong Tang, Jin Xu, Wei Wang, Qiong Du, Si Shi, Xianjun Yu
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024176281
Tags: Add Tag
No Tags, Be the first to tag this record!